CD8A and Miyoshi myopathy: Accordingly, mitigating CD8+ T cell exhaustion via TIGIT inhibition led to responses to both PD-1 and PD-L1 blockade, achieving durable MM responses (Fig. 6g and Extended Data Fig. 9f).